Since the symptomatic stage, i.e., stage two of AD, requires the activation of the AβPP-independent iAβ production pathway and, consequently, of the AD Engine, factors determining the attainment of the critical AD Engine-activating threshold by AβPP-derived iAβ play the key role in defining the susceptibility to AD. The gene discussed is APP; the disease is Alzheimer disease.